However, when PP2A inhibitor proteins, such as SET and CIP2A, are overexpressed, as is frequently found in human cancers, decreased PP2A activity allows enhanced NELF-A phosphorylation; this causes aberrant upregulation of IEGs and associated downstream growth-promoting genes, and tumor progression. The gene discussed is NELFA; the disease is neoplasm.